Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Roesch-Ely

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Psychopathology|April 8, 2003
Cognitive inhibition and thought disorder in schizophreniaDaniela Roesch-Ely, Manfred Spitzer, Matthias Weisbrod
Schizophrenia Research|March 4, 2018
Proverb comprehension deficits in patients with schizophrenia-Neurocognitive and social cognitive correlatesMargaux Mohnke, Claudia Bach, Daniela Roesch-Ely
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|May 29, 2002
Automatic vs. controlled processes in semantic priming--differentiation by event-related potentialsHolger Hill, Marion Strube, Daniela Roesch-Ely, et al.
Schizophrenia Research|July 23, 2017
Monocausal attribution and its relationship with reasoning biases in schizophreniaSteffen Moritz, Richard P Bentall, Katharina Kolbeck, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|September 29, 2007
Increased event-related potential latency and amplitude variability in schizophrenia detected through wavelet-based single trial analysisAlexander Roth, Daniela Roesch-Ely, Stephan Bender, et al.
Psychopathology|July 20, 2010
Context representation and thought disorder in schizophreniaDaniela Roesch-Ely, Manfred Spitzer, Stefan Kaiser, et al.
Journal of Behavior Therapy and Experimental Psychiatry|February 20, 2010
Metacognitive training for patients with schizophrenia (MCT): feasibility and preliminary evidence for its efficacyJulia Aghotor, Ute Pfueller, Steffen Moritz, et al.
The American Journal of Psychiatry|August 31, 2002
Myocarditis with quetiapineDaniela Roesch-Ely, Regina Van Einsiedel, Sven Kathöfer, et al.
Schizophrenia Research|February 9, 2017
Pronounced inhibition-related hypofrontal dysfunction in early-onset schizophrenia as indexed by NoGo-P300 amplitudeAnuradha Sharma, Melina Vogel, Matthias Weisbrod, et al.
Cognitive Neuropsychiatry|February 18, 2016
Reasoning in psychosis: risky but not necessarily hastySteffen Moritz, Florian Scheu, Christina Andreou, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Psychopathology|April 8, 2003
Cognitive inhibition and thought disorder in schizophreniaDaniela Roesch-Ely, Manfred Spitzer, Matthias Weisbrod
Schizophrenia Research|March 4, 2018
Proverb comprehension deficits in patients with schizophrenia-Neurocognitive and social cognitive correlatesMargaux Mohnke, Claudia Bach, Daniela Roesch-Ely
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|May 29, 2002
Automatic vs. controlled processes in semantic priming--differentiation by event-related potentialsHolger Hill, Marion Strube, Daniela Roesch-Ely, et al.
Schizophrenia Research|July 23, 2017
Monocausal attribution and its relationship with reasoning biases in schizophreniaSteffen Moritz, Richard P Bentall, Katharina Kolbeck, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|September 29, 2007
Increased event-related potential latency and amplitude variability in schizophrenia detected through wavelet-based single trial analysisAlexander Roth, Daniela Roesch-Ely, Stephan Bender, et al.
Psychopathology|July 20, 2010
Context representation and thought disorder in schizophreniaDaniela Roesch-Ely, Manfred Spitzer, Stefan Kaiser, et al.
Journal of Behavior Therapy and Experimental Psychiatry|February 20, 2010
Metacognitive training for patients with schizophrenia (MCT): feasibility and preliminary evidence for its efficacyJulia Aghotor, Ute Pfueller, Steffen Moritz, et al.
The American Journal of Psychiatry|August 31, 2002
Myocarditis with quetiapineDaniela Roesch-Ely, Regina Van Einsiedel, Sven Kathöfer, et al.
Schizophrenia Research|February 9, 2017
Pronounced inhibition-related hypofrontal dysfunction in early-onset schizophrenia as indexed by NoGo-P300 amplitudeAnuradha Sharma, Melina Vogel, Matthias Weisbrod, et al.
Cognitive Neuropsychiatry|February 18, 2016
Reasoning in psychosis: risky but not necessarily hastySteffen Moritz, Florian Scheu, Christina Andreou, et al.
Pageof 5